Antimicrobial-resistant ringworm made headlines last year when a New York City dermatologist notified public health officials of two patients whose ringworm did not improve with oral terbinafine. Since then, stubborn strains of the fungus, which causes itchy, scaly patches of skin, have appeared in at least 11 states, including New York.

Terri D’Arrigo

During a March 2024 meeting, FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) made recommendations on which influenza viruses would be best to include in influenza vaccine compositions for the 2024–2025 flu season.

Olivia C. Welter, PharmD

More than 39 million people in the United States experience migraine, according to the American Migraine Foundation. For some, the condition is an infrequent one, but for millions of others, it may be disabling, occurring so frequently and with such ferocity that nearly every aspect of their lives is affected.

Elizabeth Briand

In February 2024, FDA approved Exblifep (cefepime hydrochloride/enmetazobactam—Allecra Therapeutics), a new antibiotic that is indicated for complicated UTIs, including pyelonephritis, in individuals 18 years and older.

Lauren Howell, PharmD

Recent buzz around a veterinary medicine company developing drugs to extend the lifespan in dogs by targeting the underlying causes of aging has some wondering, if it works for dogs, will it work for humans? The promise of eternal youth has renewed interest in oxidized nicotinamide adenine dinucleotide (NAD+) supplementation.

Mickie Cathers